UBS AM’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.7M | Sell |
818,927
-77,477
| -9% | -$3.38M | 0.01% | 809 |
|
|
2025
Q1 | $24.5M | Buy |
896,404
+491,737
| +122% | +$13.5M | 0.01% | 879 |
|
|
2024
Q4 | $16.3M | Sell |
404,667
-23,862
| -6% | -$960K | ﹤0.01% | 1042 |
|
|
2024
Q3 | $20.3M | Sell |
428,529
-5,044
| -1% | -$239K | 0.01% | 945 |
|
|
2024
Q2 | $12.9M | Buy |
433,573
+253,635
| +141% | +$7.57M | ﹤0.01% | 1031 |
|
|
2024
Q1 | $7.23M | Buy |
179,938
+3,438
| +2% | +$138K | ﹤0.01% | 1116 |
|
|
2023
Q4 | $4.49M | Sell |
176,500
-13,233
| -7% | -$337K | ﹤0.01% | 1296 |
|
|
2023
Q3 | $2.64M | Buy |
189,733
+13,205
| +7% | +$184K | ﹤0.01% | 1485 |
|
|
2023
Q2 | $5.23M | Hold |
176,528
| – | – | ﹤0.01% | 1202 |
|
|
2023
Q1 | $5.23M | Sell |
176,528
-3,039
| -2% | -$90K | ﹤0.01% | 1202 |
|
|
2022
Q4 | $4.48M | Buy |
179,567
+12,022
| +7% | +$300K | ﹤0.01% | 1205 |
|
|
2022
Q3 | $3.65M | Sell |
167,545
-26,779
| -14% | -$583K | ﹤0.01% | 1316 |
|
|
2022
Q2 | $3.83M | Sell |
194,324
-235,919
| -55% | -$4.65M | ﹤0.01% | 1314 |
|
|
2022
Q1 | $18.2M | Buy |
430,243
+164,192
| +62% | +$6.95M | 0.01% | 867 |
|
|
2021
Q4 | $16.9M | Sell |
266,051
-238
| -0.1% | -$15.1K | 0.01% | 948 |
|
|
2021
Q3 | $15.6M | Sell |
266,289
-15,750
| -6% | -$925K | 0.01% | 936 |
|
|
2021
Q2 | $13.7M | Buy |
+282,039
| New | +$13.7M | 0.01% | 999 |
|